Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 06, 2015 3:25 AM ET

Health Care Technology

Company Overview of Akili Interactive Labs, Inc.

Company Overview

Akili Interactive Labs, Inc. develops platform technology that test and enhance the cognitive abilities through a video game. The company was incorporated in 2011 and is based in Boston, Massachusetts. Akili Interactive Labs, Inc. operates as a subsidiary of PureTech Health PLC.

500 Boylston Street

Suite 1600

Boston, MA 02116-3891

United States

Founded in 2011

Key Executives for Akili Interactive Labs, Inc.

Founder and Acting Chief Executive Officer
Age: 44
Co-founder
Co-founder and Chief Science Advisor
Compensation as of Fiscal Year 2015.

Akili Interactive Labs, Inc. Key Developments

Akili Interactive Labs, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 08:00 AM

Akili Interactive Labs, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 08:00 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Eric Elenko, CEO.

Akili Interactive Labs, Inc. Announces Partnership with Pfizer Inc. to Test Video Game in People at Risk of Alzheimer's Disease

Akili Interactive Labs Inc. announced that it has entered into an agreement with Pfizer Inc. to test the ability of Akili's mobile video game platform to detect cognitive differences in healthy elderly people at risk of developing Alzheimer's disease. Under the agreement, Pfizer will conduct a clinical trial that will evaluate healthy elderly subjects with and without the presence of amyloid in their brains, as determined by Positron Emission Tomography imaging. Approximately 100 individuals are expected to be enrolled with their cognitive abilities assessed both at baseline, and over the course of one month of game play. The goal of the trial is to investigate the Akili game as a biomarker or clinical endpoint for potential use in future Alzheimer's trials. The Akili video game platform is designed to quantify and improve the ability of individuals to deal with cognitive interference (distractions and interruptions), which impacts their ability to pay attention, plan and make decisions. Such deficits are common symptoms of many degenerative diseases like Alzheimer's, as well as psychiatric conditions such as ADHD, autism and depression.

Similar Private Companies By Industry

Company Name Region
Paradigm Diagnostics, Inc. United States
DigiSight Technologies, Inc. United States
Intervention Insights, Inc. United States
Thomson Reuters Recap United States
BabyWatch, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Akili Interactive Labs, Inc., please visit www.akiliinteractive.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.